Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001235802-05-000032
Filing Date
2005-04-22
Accepted
2005-04-22 16:38:56
Documents
1
Period of Report
2005-04-21

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 3081
  Complete submission text file 0001235802-05-000032.txt   4972
Mailing Address 111 BARCLAY BLVD STE 280 LINCOLNSHIRE IL 60069
Business Address 111 BARCLAY BLVD STE 280 LINCOLNSHIRE IL 60069
BIOSANTE PHARMACEUTICALS INC (Issuer) CIK: 0001023024 (see all company filings)

EIN.: 582301143 | State of Incorp.: WY | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address
Business Address 4600 HIGHLANDS PARKWAY SUITE A & B SMYRNA GA 30082 7708059769
BELL STEVEN J (Reporting) CIK: 0001241292 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-31812 | Film No.: 05767869